GEN Exclusives

More »

Apr. 15, Vol. 33, No. 8

      • Boosting Downstream Productivity
      • MaryAnn Labant
      • In 2012, BioPlan Associates estimated the global market for biopharmaceuticals at $140 billion, of which $100 billion was for recombinant proteins. The monoclonal antibody (mAb) market, a subclass of recombinant proteins, was estimated at $40 billio ... more »
      • Exploring GPCRs as Therapeutic Targets
      • Caitlin Smith
      • Recent years have seen an explosion of disease-relevant research on G-protein coupled receptors (GPCRs). Hot topics include strategies for targeting GPCRs therapeutically, and understanding the mechanisms of biased agonism. A number of distinguished ... more »
      • Single-Use Bioreactor Roundup
      • A number of bioprocess analysts estimate that the entire single-use market has been growing at about 15–20% per year. Single-use bioreactors (SUB), in particular, are rapidly increasing in popularity and seem destined to stay. GEN polled a number of ... more »
      • Stockholm-Uppsala Region Ups the Ante
      • Tamlyn Oliver
      • Putting neighboring-city rivalries aside, government agencies and the life science communities in Stockholm and Uppsala, Sweden, have joined forces with plans to create an internationally renowned life science cluster. The region is boldly ambitious ... more »
      • Hand-Held Homogenization Tool
      • Horacio Kido, Ph.D.
      • One of the largest bottlenecks in a modern life science laboratory workflow is at the beginning of the sample-preparation stage: It is the efficient lysis, homogenization, and grinding of difficult-to-lyse samples. This step is necessary in order to ... more »
    • Corporate Profiles

      • Cytomics for Personalized Heart Health
      • Carol Potera
      • CytoVas aims to improve the assessment of cardiovascular health. The early-stage, in vitro diagnostic company is working to improve its Vascular Health Profile (VHP). Based on cytomics, which analyzes cell systems and networks, VHP is a blood test t ... more »
    • Corporate Capabilities

      • Advertorial: AAIPharma Services
      • AAIPharma Services is a highly experienced provider of drug development, manufacturing, and analytical services to the pharmaceutical, biotech, and healthcare industries. For over 33 years, AAIPharma has been a leading provider and has grown into a ... more »
      • Advertorial: ACEA Biosciences
      • The year 2013 marks a significant milestone for ACEA Biosciences as the company celebrates its 10th anniversary. Over the course of the last decade ACEA has transformed itself from a small startup company to a leading provider of instrumentation for ... more »
    • People in the News

      • People in the News
      • Conkwest hired Hans Klingemann, M.D., Ph.D. , as CMO and CSO. Dr. Klingemann is a member of the board for Osiris Therapeutics. Previously, he was professor of medicine and director, bone marrow and stem cell transplant program at Tufts Medical Cance ... more »

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?